Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för George Eric Davis. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att George Eric Davis har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:BMRN / BioMarin Pharmaceutical Inc. | EVP, Chief Legal Officer | 82 915 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av George Eric Davis. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av George Eric Davis som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 940 | 82 915 | 18,49 | ||||
2025-03-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −16 249 | 69 975 | −18,85 | 69,44 | −1 128 331 | 4 859 064 | |
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 367 | 86 224 | 12,19 | ||||
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 660 | 76 857 | 14,38 | ||||
2025-02-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 040 | 67 197 | 19,66 | ||||
2024-05-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 779 | 56 157 | −4,72 | 75,29 | −209 225 | 4 227 948 |
2024-05-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −38 071 | 58 936 | −39,25 | 74,46 | −2 834 576 | 4 388 080 |
2024-05-30 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 40 850 | 97 007 | 72,74 | 63,10 | 2 577 635 | 6 121 142 |
2024-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 850 | 56 157 | −3,19 | 85,01 | −157 268 | 4 773 907 |
2024-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 1 850 | 58 007 | 3,29 | 63,10 | 116 735 | 3 660 242 |
2024-05-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 301 | 56 157 | 0,54 | 68,65 | 20 662 | 3 854 953 | |
2024-04-01 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −24 602 | 55 856 | −30,58 | 88,34 | −2 173 341 | 4 934 319 |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −21 699 | 80 458 | −21,24 | 83,87 | −1 819 895 | 6 748 012 | |
2024-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 260 | 102 157 | 11,16 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 284 | 91 897 | 7,34 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 063 | 85 613 | 11,84 | ||||
2024-02-29 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 840 | 76 550 | 37,41 | ||||
2023-12-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −13 764 | 55 710 | −19,81 | 95,30 | −1 311 709 | 5 309 163 |
2023-08-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −11 000 | 69 474 | −13,67 | 89,42 | −983 662 | 6 212 629 | |
2023-05-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −210 | 80 474 | −0,26 | ||||
2023-05-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 317 | 80 684 | 0,39 | 66,88 | 21 201 | 5 396 146 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −19 957 | 80 367 | −19,89 | 93,41 | −1 864 183 | 7 507 081 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 025 | 100 324 | −2,93 | 87,74 | −265 414 | 8 802 428 | |
2023-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 8 900 | 103 349 | 9,42 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 7 424 | 94 449 | 8,53 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 100 | 87 025 | 13,13 | ||||
2023-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 20 200 | 76 925 | 35,61 | ||||
2023-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 474 | 56 725 | 2,67 | 67,81 | 99 952 | 3 846 522 | |
2022-08-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −47 526 | 55 251 | −46,24 | 95,93 | −4 559 169 | 5 300 228 | |
2022-08-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 47 526 | 102 777 | 86,02 | 67,81 | 3 222 738 | 6 969 308 | |
2022-08-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −3 690 | 55 251 | −6,26 | 96,34 | −355 495 | 5 322 881 | |
2022-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −7 398 | 58 941 | −11,15 | 90,00 | −665 820 | 5 304 690 |
2022-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −15 347 | 0 | −100,00 | |||
2022-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −15 347 | 66 339 | −18,79 | 80,38 | −1 233 592 | 5 332 329 |
2022-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 15 347 | 81 686 | 23,13 | 37,46 | 574 899 | 3 059 958 |
2022-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 66 339 | 0,52 | 62,41 | 21 281 | 4 140 018 | |
2022-04-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | −2 669 | 0 | −100,00 | ||||
2022-04-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 669 | 65 998 | 4,21 | 37,46 | 99 981 | 2 472 285 | |
2022-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −6 129 | 63 329 | −8,82 | 81,29 | −498 226 | 5 148 014 |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 252 | 69 458 | −1,77 | 80,72 | −101 061 | 5 606 650 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 26 520 | 26 520 | |||||
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −8 290 | 70 710 | −10,49 | 78,27 | −648 858 | 5 534 472 | |
2022-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 040 | 79 000 | 16,24 | ||||
2022-03-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 370 | 67 960 | 15,99 | ||||
2021-08-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 518 | 58 590 | −8,61 | 76,69 | −423 175 | 4 493 267 |
2021-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 089 | 64 108 | −3,16 | 78,30 | −163 569 | 5 019 656 |
2021-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 584 | 66 197 | −3,76 | 78,30 | −202 327 | 5 183 225 |
2021-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 341 | 68 781 | 0,50 | 62,41 | 21 281 | 4 292 416 | |
2021-04-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 709 | 0 | −100,00 | |||
2021-04-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 709 | 68 440 | −3,81 | 79,58 | −215 582 | 5 446 455 |
2021-04-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 709 | 71 149 | 3,96 | 26,49 | 71 761 | 1 884 737 |
2021-03-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 391 | 68 440 | −1,99 | 78,52 | −109 221 | 5 373 909 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 252 | 69 831 | −1,76 | 77,21 | −96 667 | 5 391 652 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 25 650 | 25 650 | |||||
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −5 014 | 71 083 | −6,59 | 78,39 | −393 047 | 5 572 196 | |
2021-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 420 | 76 097 | 15,87 | ||||
2020-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −12 504 | 65 677 | −15,99 | 89,38 | −1 117 608 | 5 870 210 |
2020-05-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 339 | 78 181 | 0,44 | 62,59 | 21 217 | 4 893 036 | |
2020-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 309 | 77 842 | −4,08 | 73,05 | −241 722 | 5 686 358 | |
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 28 790 | 28 790 | |||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 100 | 81 151 | 14,22 | ||||
2020-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −7 244 | 71 051 | −9,25 | 84,50 | −612 118 | 6 003 810 | |
2020-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 586 | 78 295 | 13,95 | ||||
2019-11-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 190 | 68 709 | −4,44 | 79,66 | −254 115 | 5 473 359 |
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −300 | 71 899 | −0,42 | ||||
2019-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 72 199 | 0,43 | 68,78 | 21 254 | 4 965 992 | |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 363 | 71 890 | −4,47 | 87,86 | −295 473 | 6 316 255 |
2019-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 309 | 75 253 | −4,21 | 88,05 | −291 357 | 6 626 027 | |
2019-03-21 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −7 907 | 78 562 | −9,14 | 93,92 | −742 625 | 7 378 543 |
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 23 450 | 23 450 | |||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 370 | 86 469 | 12,15 | ||||
2019-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −6 648 | 77 099 | −7,94 | 94,53 | −628 435 | 7 288 168 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −840 | 83 747 | −0,99 | 94,76 | −79 598 | 7 935 866 | |
2019-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 853 | 84 587 | 16,30 | ||||
2018-09-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −616 | 72 734 | −0,84 | 99,46 | −61 265 | 7 233 833 | |
2018-09-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −200 | 73 350 | −0,27 | 99,46 | −19 891 | 7 295 024 | |
2018-09-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 400 | 73 550 | −1,87 | 99,45 | −139 230 | 7 314 548 | |
2018-09-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −12 000 | 74 950 | −13,80 | 99,57 | −1 194 840 | 7 462 772 | |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 414 | 86 950 | −1,60 | 92,07 | −130 187 | 8 005 486 | |
2018-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 309 | 88 364 | 0,35 | 68,78 | 21 254 | 6 077 853 | |
2018-04-27 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 308 | 91 326 | −3,50 | 81,36 | −269 139 | 7 430 283 | |
2018-04-26 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 601 | 94 343 | 14,02 | ||||
2018-03-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 350 | 87 989 | −3,67 | 81,35 | −272 522 | 7 157 905 |
2018-03-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 295 | 91 339 | −3,48 | 81,36 | −268 081 | 7 431 341 | |
2018-03-20 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −3 818 | 94 634 | −3,88 | 83,88 | −320 254 | 7 937 900 |
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 38 760 | 38 760 | |||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 12 120 | 98 452 | 14,04 | ||||
2018-03-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −3 757 | 86 332 | −4,17 | 83,57 | −313 972 | 7 214 765 | |
2018-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 105 | 90 089 | −2,28 | 79,04 | −166 379 | 7 120 635 |
2018-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 071 | 92 194 | −2,20 | 79,86 | −165 390 | 7 362 613 | |
2018-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 523 | 94 265 | 13,93 | ||||
2018-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −200 | 82 742 | −0,24 | ||||
2018-02-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −30 000 | 0 | −100,00 | |||
2018-02-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −30 000 | 82 942 | −26,56 | 90,66 | −2 719 665 | 7 519 148 |
2018-02-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 30 000 | 112 942 | 36,17 | 38,59 | 1 157 700 | 4 358 432 |
2017-12-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 200 | 82 942 | −1,43 | 85,64 | −102 767 | 7 103 070 | |
2017-10-13 |
|
4/A | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
J - Other | 0 | 66 960 | 0,00 | ||||
2017-06-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −9 844 | 30 000 | −24,71 | |||
2017-06-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −9 844 | 83 581 | −10,54 | 96,60 | −950 930 | 8 073 925 |
2017-06-27 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 9 844 | 93 425 | 11,78 | 38,59 | 379 880 | 3 605 271 |
2017-06-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | −3 775 | 0 | −100,00 | ||||
2017-06-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | −5 464 | 0 | −100,00 | ||||
2017-06-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 775 | 83 581 | 4,73 | 26,49 | 100 000 | 2 214 061 | |
2017-06-13 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 5 464 | 79 806 | 7,35 | 21,51 | 117 531 | 1 716 627 | |
2017-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −9 471 | 74 342 | −11,30 | 91,04 | −862 230 | 6 768 021 | |
2017-06-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 488 | 83 813 | −1,74 | 90,72 | −134 991 | 7 603 515 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | −1 146 | 0 | −100,00 | ||||
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 146 | 85 301 | 1,36 | 14,39 | 16 491 | 1 227 481 | |
2017-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 84 155 | −1,29 | 91,50 | −100 284 | 7 700 182 | |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
M - Exercise | X | −2 500 | 39 844 | −5,90 | |||
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 500 | 85 251 | −2,85 | 100,34 | −250 852 | 8 554 171 |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 2 500 | 87 751 | 2,93 | 38,59 | 96 475 | 3 386 311 |
2017-05-09 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 302 | 85 251 | 0,36 | 70,30 | 21 232 | 5 993 486 | |
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy Common Stock) |
A - Award | 36 280 | 36 820 | 6 718,52 | ||||
2017-03-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 220 | 84 949 | 15,22 | ||||
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 238 | 73 729 | −2,95 | 91,96 | −205 806 | 6 780 119 |
2017-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 995 | 75 967 | −3,79 | 92,50 | −277 038 | 7 026 948 | |
2017-03-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 498 | 78 962 | −1,86 | 93,32 | −139 793 | 7 368 734 |
2017-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 596 | 80 460 | −1,95 | 93,95 | −149 944 | 7 559 217 | |
2017-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 258 | 82 056 | 15,90 | ||||
2016-11-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
M - Exercise | X | −5 000 | 42 344 | −10,56 | 38,59 | −192 950 | 1 634 055 |
2016-11-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −5 000 | 70 798 | −6,60 | 90,42 | −452 100 | 6 401 555 |
2016-11-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 5 000 | 75 798 | 7,06 | 38,59 | 192 950 | 2 925 045 |
2016-11-22 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −360 | 70 798 | −0,51 | ||||
2016-08-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 167 | 71 158 | −2,96 | 100,00 | −216 700 | 7 115 800 |
2016-07-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
M - Exercise | −2 656 | 4 823 | −35,51 | 38,59 | −102 495 | 186 120 | |
2016-07-18 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 656 | 73 325 | 3,76 | 38,59 | 102 495 | 2 829 612 | |
2016-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −2 167 | 70 669 | −2,98 | 90,00 | −195 030 | 6 360 210 |
2016-07-11 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −120 | 72 836 | −0,16 | ||||
2016-06-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 488 | 72 956 | −2,00 | 90,00 | −133 920 | 6 566 040 | |
2016-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 74 444 | −1,45 | 82,71 | −90 650 | 6 157 263 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −4 658 | 75 540 | −5,81 | 86,32 | −402 079 | 6 520 628 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −10 000 | 80 198 | −11,09 | 84,55 | −845 532 | 6 780 998 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 696 | 90 198 | −1,85 | 80,80 | −137 037 | 7 287 998 | |
2016-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 414 | 91 894 | 0,45 | 51,26 | 21 223 | 4 710 854 | |
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to buy) Common Stock |
A - Award | 34 270 | 34 270 | |||||
2016-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 15 290 | 91 480 | 20,07 | ||||
2016-03-16 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 996 | 76 190 | −2,55 | 86,21 | −172 079 | 6 568 492 | |
2016-03-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −2 180 | 78 186 | −2,71 | 89,57 | −195 263 | 7 003 120 | |
2016-03-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −17 656 | 80 366 | −18,01 | 81,87 | −1 445 497 | 6 579 564 | |
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 5 328 | 98 022 | 5,75 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 19 840 | 92 694 | 27,23 | ||||
2016-02-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 6 860 | 72 854 | 10,39 | ||||
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 18 | 65 994 | 0,03 | 51,26 | 923 | 3 383 083 | |
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −105 | 65 976 | −0,16 | ||||
2016-02-12 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −75 | 66 081 | −0,11 | ||||
2015-12-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −1 362 | 66 156 | −2,02 | 100,00 | −136 200 | 6 615 600 |
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −120 | 67 618 | −0,18 | ||||
2015-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 488 | 67 738 | −2,15 | 120,46 | −179 244 | 8 159 719 | |
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −2 558 | 69 226 | −3,56 | 125,26 | −320 415 | 8 671 249 | |
2015-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 71 784 | −1,50 | 122,78 | −134 567 | 8 813 640 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 696 | 72 880 | −2,27 | 121,66 | −206 335 | 8 866 581 | |
2015-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 730 | 74 576 | 0,99 | 51,26 | 37 422 | 3 823 027 | |
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −14 484 | 15 347 | −48,55 | ||||
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −516 | 2 709 | −16,00 | ||||
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −15 000 | 73 846 | −16,88 | 120,87 | −1 813 002 | 8 925 530 | |
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 14 484 | 88 846 | 19,48 | 37,46 | 542 571 | 3 328 171 | |
2015-03-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 516 | 74 362 | 0,70 | 26,49 | 13 669 | 1 969 849 | |
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 21 900 | 21 900 | |||||
2015-03-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 9 600 | 73 846 | 14,94 | ||||
2015-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −20 000 | 3 225 | −86,11 | 26,49 | −529 800 | 85 430 | |
2015-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −23 000 | 64 246 | −26,36 | 108,31 | −2 491 026 | 6 958 195 | |
2015-03-04 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 23 000 | 87 246 | 35,80 | 26,49 | 609 270 | 2 311 147 | |
2015-02-03 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −180 | 64 246 | −0,28 | ||||
2014-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 26 225 | −43,27 | 26,49 | −529 800 | 694 700 |
2014-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −20 000 | 64 426 | −23,69 | 89,75 | −1 795 000 | 5 782 234 |
2014-11-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 84 426 | 31,04 | 26,49 | 529 800 | 2 236 445 |
2014-11-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −15 000 | 46 225 | −24,50 | 26,49 | −397 350 | 1 224 500 | |
2014-11-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −15 000 | 64 426 | −18,89 | 83,20 | −1 247 930 | 5 359 940 | |
2014-11-03 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 15 000 | 79 426 | 23,28 | 26,49 | 397 350 | 2 103 995 | |
2014-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | 17 536 | 0 | −100,00 | 21,51 | 377 199 | ||
2014-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | X | −17 536 | 64 426 | −21,40 | 69,75 | −1 223 136 | 4 493 714 |
2014-09-23 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 17 536 | 81 962 | 27,22 | 21,51 | 377 199 | 1 763 003 |
2014-06-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 42 700 | 42 700 | |||||
2014-06-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 11 400 | 64 426 | 21,50 | ||||
2014-06-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
D - Sale to Issuer | X | −3 562 | 53 026 | −6,29 | 60,00 | −213 720 | 3 181 560 |
2014-06-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
G - Gift | −180 | 56 588 | −0,32 | 23,21 | −4 178 | 1 313 407 | |
2014-05-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 56 768 | −1,89 | 57,44 | −62 954 | 3 260 754 | |
2014-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 57 864 | −1,86 | 59,30 | −64 993 | 3 431 335 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 696 | 58 960 | −2,80 | 56,78 | −96 299 | 3 347 749 | |
2014-05-12 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 704 | 61 360 | 1,16 | 29,69 | 20 902 | 1 821 778 | |
2014-02-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | X | −20 000 | 17 536 | −53,28 | 21,51 | −430 200 | 377 199 |
2014-02-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 60 656 | −24,80 | 80,00 | −1 600 000 | 4 852 480 | |
2014-02-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | X | 20 000 | 80 656 | 32,97 | 21,51 | 430 200 | 1 734 911 |
2014-02-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 10 500 | 60 656 | 20,93 | ||||
2014-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 48 | 50 156 | 0,10 | 27,91 | 1 339 | 1 399 628 | |
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
A - Award | 49 000 | 49 000 | |||||
2013-05-17 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 8 400 | 50 108 | 20,14 | ||||
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −20 000 | 37 536 | −34,76 | 21,51 | −430 200 | 807 399 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 41 708 | −32,41 | 70,34 | −1 406 800 | 2 933 741 | |
2013-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 20 000 | 61 708 | 47,95 | 21,51 | 430 200 | 1 327 339 | |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −2 590 | 41 708 | −5,85 | 69,29 | −179 452 | 2 889 801 | |
2013-05-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 096 | 44 298 | −2,41 | 67,68 | −74 177 | 2 998 089 | |
2013-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −1 664 | 45 394 | −3,54 | 65,32 | −108 692 | 2 965 136 | |
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −2 292 | 1 147 | −66,65 | ||||
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 562 | 0 | −100,00 | ||||
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 854 | 47 058 | −11,06 | 67,19 | −393 327 | 3 161 803 | |
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 2 292 | 52 912 | 4,53 | 14,39 | 32 982 | 761 404 | |
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 562 | 50 620 | 7,57 | 17,54 | 62 477 | 887 875 | |
2013-05-07 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 858 | 47 058 | 1,86 | 23,20 | 19 910 | 1 091 981 | |
2013-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −4 000 | 0 | −100,00 | 17,86 | −71 440 | ||
2013-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −4 000 | 46 200 | −7,97 | 60,18 | −240 724 | 2 780 367 | |
2013-03-06 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 000 | 50 200 | 8,66 | 17,86 | 71 440 | 896 572 | |
2013-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −4 583 | 221 500 | −2,03 | 14,39 | −65 949 | 3 187 385 | |
2013-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −3 417 | 226 083 | −1,49 | ||||
2013-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −8 000 | 46 200 | −14,76 | 56,90 | −455 186 | 2 628 697 | |
2013-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 4 583 | 54 200 | 9,24 | 14,39 | 65 949 | 779 938 | |
2013-02-28 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 3 417 | 49 617 | 7,40 | 17,54 | 59 934 | 870 282 | |
2013-02-14 |
|
5 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
F - Taxes | −771 | 46 200 | −1,64 | 38,00 | −29 298 | 1 755 600 | |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −7 363 | 229 500 | −3,11 | ||||
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −7 363 | 51 322 | −12,55 | 48,50 | −357 106 | 2 489 117 | |
2012-11-19 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 7 363 | 58 685 | 14,35 | 17,54 | 129 147 | 1 029 335 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −10 137 | 236 863 | −4,10 | ||||
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −10 137 | 51 322 | −16,49 | 48,63 | −492 966 | 2 495 809 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −1 438 | 61 459 | −2,29 | 48,70 | −70 032 | 2 993 115 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 10 137 | 62 897 | 19,21 | 17,54 | 177 803 | 1 103 213 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 329 | 52 651 | 2,59 | 38,00 | 50 502 | 2 000 738 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −35 521 | 247 000 | −12,57 | ||||
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) Common Stock |
M - Exercise | −6 979 | 282 521 | −2,41 | ||||
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to Buy) |
M - Exercise | −45 000 | 289 500 | −13,45 | ||||
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −17 500 | 51 322 | −25,43 | 48,55 | −849 641 | 2 491 729 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −50 000 | 68 822 | −42,08 | 48,55 | −2 427 655 | 3 341 521 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −20 000 | 118 822 | −14,41 | 48,00 | −960 000 | 5 703 456 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 35 521 | 138 822 | 34,39 | 17,54 | 623 038 | 2 434 938 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 6 979 | 103 301 | 7,25 | 14,39 | 100 428 | 1 486 501 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 45 000 | 96 322 | 87,68 | 17,33 | 779 850 | 1 669 260 | |
2012-11-14 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 109 | 52 760 | 0,21 | 21,76 | 2 372 | 1 148 058 | |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (Right to Buy) |
M - Exercise | −40 000 | 334 500 | −10,68 | 14,39 | −575 600 | 4 813 455 | |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −5 000 | 51 322 | −8,88 | 38,08 | −190 401 | 1 954 352 | |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −35 000 | 56 322 | −38,33 | 37,94 | −1 328 033 | 2 137 071 | |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | −40 000 | 91 322 | −30,46 | 14,39 | −575 600 | 1 314 124 | |
2012-05-15 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
S - Sale | −2 309 | 51 322 | −4,31 | 37,07 | −85 595 | 1 902 507 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 32 500 | 374 500 | 9,50 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 000 | 53 631 | 32,00 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 980 | 40 631 | 2,47 | 19,35 | 18 959 | 786 047 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 32 500 | 374 500 | 9,50 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 000 | 53 631 | 32,00 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 980 | 40 631 | 2,47 | 19,35 | 18 959 | 786 047 | |
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Stock Option (right to buy) |
A - Award | 32 500 | 374 500 | 9,50 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 13 000 | 53 631 | 32,00 | ||||
2012-05-10 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 980 | 40 631 | 2,47 | 19,35 | 18 959 | 786 047 | |
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −1 500 | 5 000 | −23,08 | ||||
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 500 | 33 558 | 4,68 | ||||
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Restricted Stock Units |
M - Exercise | −1 750 | 6 500 | −21,21 | ||||
2010-06-08 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
M - Exercise | 1 750 | 31 808 | 5,82 |